April 2, 2008, Brisbane, CA--Aesthetic-laser provider Cutera is presenting a new fractional ablative
technology designed for the treatment of wrinkles this week at the American Society for Laser Medicine & Surgery Conference (ASLMS) in Kissimmee, FL (April 2-6).
In 2007, Cutera introduced its proprietary 2790 nm YSGG technology with the Pearl laser for epidermal treatments to improve fine lines, texture and pigment. Cutera's new device targets the deeper dermal layer with the objective of improving wrinkles. This is the logical next step in the evolution of YSGG in this emerging and growing fractional ablative market.
E. Victor Ross, MD, who performed the initial clinical studies
with Pearl, comments, "My confidence in the 2790 nm YSGG wavelength for treating epidermal photo-aging conditions has evolved over the past 18 months. The hybrid mechanism of ablation and coagulation is a characteristic of the 2790 nm wavelength. Using this wavelength, Cutera's latest device will have the ability to create micro-wounds targeting the dermal layer. The skin's response to these wounds should result in the improvement of wrinkles."
"Cutera's Pearl device has allowed me to effectively treat
pigment, texture and fine lines, while renewing the entire skin's surface," adds David J. Goldberg, MD. "With the combination of Pearl and fractional ablative YSGG, we are able to not only treat the entire epidermis, but expect to also stimulate collagen in the deep dermis to address wrinkles. This dual approach has the potential to provide an ideal solution to meet the various needs of my patients."
The device is pending FDA clearance and should be available in the second half of the year on Cutera's multi-application Xeo platform, as an upgrade to existing customers, and as a standalone unit.
